Equities

Ecomax Inc

EMAX:PKL

Ecomax Inc

Actions
  • Price (USD)0.178
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change--
  • Beta-2.7470
Data delayed at least 15 minutes, as of Oct 23 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.

  • Revenue in USD (TTM)799.16k
  • Net income in USD-51.60k
  • Incorporated2006
  • Employees24.00
  • Location
    Ecomax Inc40 WALL STREET, 28TH FLOORNEW YORK 10005United StatesUSA
  • Phone+1 (323) 552-9867
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sharing Services Global Corp10.22m-5.26m104.83k32.00------0.0103-19.67-19.6738.26-13.971.542.1924.53319,426.30-79.23-50.60---575.0764.1569.87-51.42-23.270.2995-1.45-----32.44-33.8682.19------
Better for You Wellness Inc18.20k-1.79m355.46k4.00------19.53-0.0041-0.00410.00004-0.0050.03550.45683.464,550.00-349.59------28.46---9,846.98--0.0093-4.19-----9.55--30.43------
Ecomax Inc799.16k-51.60k423.81k24.00------0.5303-0.0217-0.02170.3357-0.14267.4712.9513.11---48.26-537.02----25.58---6.46-106.620.092-0.7022--------21.54------
Mushrooms Inc47.99k-132.43k647.73k34.00--0.0007--13.50-7.27-7.272.6425.390.0876--6.39---24.18-23.32-25.60-24.1035.40---275.95-192.18----0.00--63.74-20.74-36.67------
Nowfinance Inc4.08m-2.10m686.68k25.00------0.1684-0.224-0.2240.4345-1.060.840316.48--163,089.60-43.32------63.37---51.55--0.3264-0.80123.26---5.64--15.09------
Global Roundtable Corp3.55m1.78m722.68k20.000.028--2.800.20350.00360.00360.00740.03320.3053--768.00--15.28-105.4320.12-375.9666.6679.2950.05-2,205.90----0.0691------438.46------
Right On Brands Inc1.40m-411.63k1.62m2.00------1.16-0.0162-0.01620.0559-0.03167.076.12-----207.37-433.00----57.1742.03-29.33-417.120.0742-0.2224----13.92161.22103.40------
Data as of Oct 23 2024. Currency figures normalised to Ecomax Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.